13,14-Dihydro-15-keto prostaglandin E1
- CAS No.
- 5094-14-4
- Chemical Name:
- 13,14-Dihydro-15-keto prostaglandin E1
- Synonyms
- U 21002;13,14-dihydro-15-keto PGE1;CDUVSQMTLOYKTR-ZHALLVOQSA-N;13,14-Dihydro-15-keto prostaglandin E1;9,15-dioxo-11α-hydroxy-prostan-1-oic acid;9,15-DIOXO-11ALPHA-HYDROXY-PROSTAN-1-OIC ACID;Prostan-1-oic acid, 11-hydroxy-9,15-dioxo-, (11α)-;15-Keto Prostaglandin E0 DISCONTINUED, OFFER K202056
- CBNumber:
- CB4190392
- Molecular Formula:
- C20H34O5
- Molecular Weight:
- 354.49
- MDL Number:
- MFCD00135210
- MOL File:
- 5094-14-4.mol
- MSDS File:
- SDS
- TDS File:
- TDS
| Boiling point | 537.2±35.0 °C(Predicted) |
|---|---|
| Density | 1.072±0.06 g/cm3(Predicted) |
| storage temp. | -20°C Freezer, Under inert atmosphere |
| solubility | DMSO (Slightly), Methanol (Slightly), THF (Slightly) |
| pka | 4.77±0.10(Predicted) |
| form | Oil |
| color | Dark Yellow |
| FDA UNII | M3I99MYM0V |
13,14-Dihydro-15-keto prostaglandin E1 price More Price(10)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Cayman Chemical | 13650 | 13,14-dihydro-15-keto Prostaglandin E1 ≥98% | 5094-14-4 | 1mg | $71 | 2026-04-30 | Buy |
| Cayman Chemical | 13650 | 13,14-dihydro-15-keto Prostaglandin E1 ≥98% | 5094-14-4 | 5mg | $308 | 2026-04-30 | Buy |
| Cayman Chemical | 13650 | 13,14-dihydro-15-keto Prostaglandin E1 ≥98% | 5094-14-4 | 10mg | $547 | 2026-04-30 | Buy |
| ChemScene | CS-0140520 | 13,14-Dihydro-15-keto-PGE1 | 5094-14-4 | 1mg | $153 | 2026-06-04 | Buy |
| ChemScene | CS-0140520 | 13,14-Dihydro-15-keto-PGE1 | 5094-14-4 | 5mg | $667 | 2026-06-04 | Buy |
13,14-Dihydro-15-keto prostaglandin E1 Chemical Properties, Uses, Production
Description
13,14-
Uses
15-Keto Prostaglandin E0 is a metabolite of Prostaglandin E1 (P838600) and has been shown to induce arterial thromboresistance in experimental animals and in man, but with several magnitudes higher concentrations than Prostaglandin E1. 15-Keto Prostaglandin E0 is also used as the active ingredient in compositions used for the treatment of external secretion disorders.
Definition
ChEBI: 13,14-dihydro-15-oxoprostaglandin E1 is a prostaglandin E obtained by formal oxidation of the 15-hydroxy group and hydrogenation of the 13,14-double bond of prostaglandin E1. It has a role as a human xenobiotic metabolite. It is functionally related to a prostaglandin E1. It is a conjugate acid of a 13,14-dihydro-15-oxoprostaglandin E1(1-).
References
[1] R. KATZENSCHLAGER . Synergism between PGE1-metabolites (13,14-dihydro-prostaglandin E1, 15-keto prostaglandin E1, 15-keto-13,14-dihydro-prostaglandin E1) and nitric oxide (NO) on platelet aggregation[J]. Prostaglandins, leukotrienes, and essential fatty acids, 1992, 45 3: Pages 207-210. DOI: 10.1016/0952-3278(92)90114-x
13,14-Dihydro-15-keto prostaglandin E1 Preparation Products And Raw materials
Raw materials
Preparation Products
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Quality Control Solutions Ltd. | 0755-66853366 13670046396 | orders@qcsrm.com | China | 18188 | 56 |
| Shenzhen Polymeri Biochemical Technology Co., Ltd. | +86-400-002-6226 | sales@rrkchem.com | China | 57336 | 58 |
| ChemeGen(Shanghai) Biotechnology Co.,Ltd. | 18818260767 | sales@chemegen.com | China | 11123 | 58 |
| SHENZHEN PHYSTANDARD BIO-TECH CO.,LTD | 0755-83725350 13380397412 | 3001280422@qq.com | China | 10000 | 58 |
| Energy Chemical | 021-58432009 400-005-6266 | marketing@energy-chemical.com | China | 44871 | 58 |
| Hubei Aiputi Bioengineering Co., Ltd. | 17762444226 | d17762444226@163.com | China | 2400 | 58 |
| Shanghai Yifei Biotechnology Co. , Ltd. | 021-65675885 18964387627 | customer_service@efebio.com | China | 11963 | 58 |
